{"id":27972,"date":"2015-12-22T00:00:00","date_gmt":"2015-12-22T05:00:00","guid":{"rendered":"http:\/\/ashleydev.com\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/"},"modified":"2020-08-27T11:38:44","modified_gmt":"2020-08-27T15:38:44","slug":"radiopharmaceuticals-and-disease-diagnosis-2","status":"publish","type":"post","link":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/","title":{"rendered":"Radiopharmaceuticals and Disease&nbsp;Diagnosis"},"content":{"rendered":"<p>Nuclear medicine, already well-established in <a href=\"http:\/\/www.cancer.ca\/en\/cancer-information\/diagnosis-and-treatment\/tests-and-procedures\/nuclear-medicine-imaging\/?region=on\">cancer diagnostics and treatment<\/a>, has started to play a role in other diseases, like Alzheimer\u2019s.<\/p>\n<p>Doctors are using medications that contain radioactive materials so they can get an inside look at how your body operates. Patients receive these <a href=\"http:\/\/www.prostatecancer.ca\/Prostate-Cancer\/Treatment\/Drugs-to-Treat-Prostate-Cancer\/Radiopharmaceuticals#.VdTg5HvffkA\">radiopharmaceuticals<\/a> by injection, or by inhaling or swallowing the medication.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" size-large wp-image-12575 alignright\" src=\"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg\" alt=\"pharmaceuticalslabRADIO\" width=\"1024\" height=\"683\" srcset=\"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg 1024w, https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-300x200.jpg 300w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/p>\n<p>As oncologist <a href=\"http:\/\/www.oncology.med.ualberta.ca\/AboutUs\/FacultyMembers\/Pages\/default.aspx?P=43\">Sandy McEwan<\/a> explains, \u201cIt circulates and binds at the site of the target and then we measure the distribution of the injection in space or time to understand what changes or functions are occurring.\u201d<\/p>\n<p>Dr. McEwan is a professor and chair of the department of oncology at the University of Alberta\u2019s Cross Cancer Institute in Edmonton. He is also a member of the <a href=\"http:\/\/www.nuclearsafety.gc.ca\/\">Canadian Nuclear Safety Commission<\/a>, the independent nuclear regulator.<\/p>\n<p>Dr. McEwan says advances in nuclear medicine are growing thanks to strong and active research and development.<\/p>\n<p>The U.S. Food and Drug Administration (FDA) <a href=\"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm372261.htm\">recently approved<\/a> the use of radiopharmaceuticals to help evaluate patients for Alzheimer\u2019s disease and dementia.<\/p>\n<p>Advances are also being made in other areas such as cancer behaviours, according to Dr. McEwan.<\/p>\n<p>\u201cTumors tend to use more glucose or sugar than regular cells,\u201d Dr. McEwan says. \u201cUsing radiopharmaceuticals, doctors can measure how much glucose is being used by a tumor. The more sugar used by the cancerous cell, the worse the tumor is.\u201d<\/p>\n<p>These new medicines aren\u2019t just used for diagnoses. Their very nature allows doctors to tailor them to individual patients.<\/p>\n<p>\u201cIt\u2019s personalized medicine,\u201d says Dr. McEwan. \u201cThe right dose of the right drug, at the right time, for the right patient.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nuclear medicine, already well-established in cancer diagnostics and treatment, has started to play a role in other diseases, like Alzheimer\u2019s. Doctors are using medications that contain radioactive materials so they can get an inside look at how your body operates. Patients receive these radiopharmaceuticals by injection, or by inhaling or swallowing the medication. As oncologist [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[537],"tags":[],"topic":[],"class_list":["post-27972","post","type-post","status-publish","format-standard","hentry","category-talknuclear"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Radiopharmaceuticals and Disease Diagnosis - Association nucl\u00e9aire canadienne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Radiopharmaceuticals and Disease Diagnosis - Association nucl\u00e9aire canadienne\" \/>\n<meta property=\"og:description\" content=\"Nuclear medicine, already well-established in cancer diagnostics and treatment, has started to play a role in other diseases, like Alzheimer\u2019s. Doctors are using medications that contain radioactive materials so they can get an inside look at how your body operates. Patients receive these radiopharmaceuticals by injection, or by inhaling or swallowing the medication. As oncologist [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Association nucl\u00e9aire canadienne\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/canadanuclear\" \/>\n<meta property=\"article:published_time\" content=\"2015-12-22T05:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-08-27T15:38:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg\" \/>\n<meta name=\"author\" content=\"cna_admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cna_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/\"},\"author\":{\"name\":\"cna_admin\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/person\\\/b0c8179b9b04ade90057bc7a30b2fbd2\"},\"headline\":\"Radiopharmaceuticals and Disease&nbsp;Diagnosis\",\"datePublished\":\"2015-12-22T05:00:00+00:00\",\"dateModified\":\"2020-08-27T15:38:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/\"},\"wordCount\":272,\"publisher\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/pharmaceuticalslabRADIO-1024x683.jpg\",\"articleSection\":[\"Talk Nuclear\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/\",\"name\":\"Radiopharmaceuticals and Disease Diagnosis - Association nucl\u00e9aire canadienne\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/pharmaceuticalslabRADIO-1024x683.jpg\",\"datePublished\":\"2015-12-22T05:00:00+00:00\",\"dateModified\":\"2020-08-27T15:38:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/pharmaceuticalslabRADIO-1024x683.jpg\",\"contentUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2015\\\/11\\\/pharmaceuticalslabRADIO-1024x683.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/2015\\\/12\\\/22\\\/radiopharmaceuticals-and-disease-diagnosis-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cna.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Radiopharmaceuticals and Disease&nbsp;Diagnosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/\",\"name\":\"Canadian Nuclear Association\",\"description\":\"The national voice of the Canadian nuclear industry since 1960\",\"publisher\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cna.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#organization\",\"name\":\"Canadian Nuclear Association\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-cna-logo-only.png\",\"contentUrl\":\"https:\\\/\\\/cna.ca\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/cropped-cna-logo-only.png\",\"width\":512,\"height\":512,\"caption\":\"Canadian Nuclear Association\"},\"image\":{\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/canadanuclear\",\"https:\\\/\\\/x.com\\\/canadanuclear\",\"https:\\\/\\\/www.instagram.com\\\/canadanuclear\",\"https:\\\/\\\/www.youtube.com\\\/CanadaNuclear\",\"http:\\\/\\\/www.linkedin.com\\\/company\\\/canadian-nuclear-association\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/cna.ca\\\/fr\\\/#\\\/schema\\\/person\\\/b0c8179b9b04ade90057bc7a30b2fbd2\",\"name\":\"cna_admin\",\"url\":\"https:\\\/\\\/cna.ca\\\/fr\\\/author\\\/cna_admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Radiopharmaceuticals and Disease Diagnosis - Association nucl\u00e9aire canadienne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Radiopharmaceuticals and Disease Diagnosis - Association nucl\u00e9aire canadienne","og_description":"Nuclear medicine, already well-established in cancer diagnostics and treatment, has started to play a role in other diseases, like Alzheimer\u2019s. Doctors are using medications that contain radioactive materials so they can get an inside look at how your body operates. Patients receive these radiopharmaceuticals by injection, or by inhaling or swallowing the medication. As oncologist [&hellip;]","og_url":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/","og_site_name":"Association nucl\u00e9aire canadienne","article_publisher":"http:\/\/www.facebook.com\/canadanuclear","article_published_time":"2015-12-22T05:00:00+00:00","article_modified_time":"2020-08-27T15:38:44+00:00","og_image":[{"url":"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg","type":"","width":"","height":""}],"author":"cna_admin","twitter_misc":{"Written by":"cna_admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#article","isPartOf":{"@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/"},"author":{"name":"cna_admin","@id":"https:\/\/cna.ca\/fr\/#\/schema\/person\/b0c8179b9b04ade90057bc7a30b2fbd2"},"headline":"Radiopharmaceuticals and Disease&nbsp;Diagnosis","datePublished":"2015-12-22T05:00:00+00:00","dateModified":"2020-08-27T15:38:44+00:00","mainEntityOfPage":{"@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/"},"wordCount":272,"publisher":{"@id":"https:\/\/cna.ca\/fr\/#organization"},"image":{"@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg","articleSection":["Talk Nuclear"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/","url":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/","name":"Radiopharmaceuticals and Disease Diagnosis - Association nucl\u00e9aire canadienne","isPartOf":{"@id":"https:\/\/cna.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#primaryimage"},"image":{"@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#primaryimage"},"thumbnailUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg","datePublished":"2015-12-22T05:00:00+00:00","dateModified":"2020-08-27T15:38:44+00:00","breadcrumb":{"@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#primaryimage","url":"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg","contentUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2015\/11\/pharmaceuticalslabRADIO-1024x683.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/cna.ca\/fr\/2015\/12\/22\/radiopharmaceuticals-and-disease-diagnosis-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cna.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Radiopharmaceuticals and Disease&nbsp;Diagnosis"}]},{"@type":"WebSite","@id":"https:\/\/cna.ca\/fr\/#website","url":"https:\/\/cna.ca\/fr\/","name":"Canadian Nuclear Association","description":"The national voice of the Canadian nuclear industry since 1960","publisher":{"@id":"https:\/\/cna.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cna.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/cna.ca\/fr\/#organization","name":"Canadian Nuclear Association","url":"https:\/\/cna.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cna.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/cna.ca\/wp-content\/uploads\/2023\/12\/cropped-cna-logo-only.png","contentUrl":"https:\/\/cna.ca\/wp-content\/uploads\/2023\/12\/cropped-cna-logo-only.png","width":512,"height":512,"caption":"Canadian Nuclear Association"},"image":{"@id":"https:\/\/cna.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/canadanuclear","https:\/\/x.com\/canadanuclear","https:\/\/www.instagram.com\/canadanuclear","https:\/\/www.youtube.com\/CanadaNuclear","http:\/\/www.linkedin.com\/company\/canadian-nuclear-association"]},{"@type":"Person","@id":"https:\/\/cna.ca\/fr\/#\/schema\/person\/b0c8179b9b04ade90057bc7a30b2fbd2","name":"cna_admin","url":"https:\/\/cna.ca\/fr\/author\/cna_admin\/"}]}},"_links":{"self":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts\/27972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/comments?post=27972"}],"version-history":[{"count":1,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts\/27972\/revisions"}],"predecessor-version":[{"id":28608,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/posts\/27972\/revisions\/28608"}],"wp:attachment":[{"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/media?parent=27972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/categories?post=27972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/tags?post=27972"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/cna.ca\/fr\/wp-json\/wp\/v2\/topic?post=27972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}